PE20011092A1 - Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel - Google Patents

Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel

Info

Publication number
PE20011092A1
PE20011092A1 PE2001000150A PE2001000150A PE20011092A1 PE 20011092 A1 PE20011092 A1 PE 20011092A1 PE 2001000150 A PE2001000150 A PE 2001000150A PE 2001000150 A PE2001000150 A PE 2001000150A PE 20011092 A1 PE20011092 A1 PE 20011092A1
Authority
PE
Peru
Prior art keywords
compositions
active agent
pharmaceutically active
skin irritation
topical delivery
Prior art date
Application number
PE2001000150A
Other languages
English (en)
Inventor
Paul Robert Tanner
Thomas Edward Huetter
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE20011092A1 publication Critical patent/PE20011092A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: a) DE 1% A 50% EN PESO DE POR LO MENOS UN FOSFOLIPIDO TAL COMO FOSFOLIPIDOS INSATURADOS, PARCIALMENTE SATURADOS O SUS MEZCLAS DE PREFERENCIA LECITINA, FOSFATIDILCOLINA, FOSFADILETANOAMINA, FOSFATIDILSERINA, ENTRE OTROS ; b) DE 0,1% A 50% EN PESO DE POR LO MENOS UN AGENTE ACONDICIONADOR DE LA PIEL TAL COMO PETROLATO, PARAFINALIQUIDA, CERA DE PARAFINA, CERA DE ABEJAS , ESPERMACETI, ALCOHOL CETILICO, ENTRE OTROS, DE PREFERENCIA GLICERINA, PETROLATO, LANOLINA; c) DE 0,01% A 10% DE POR LO MENOS UN AGENTE FARMACEUTICAMNERTE ACTIVO; d) UN PORTADOR. LA COMPOSICIONES ES UTIL PARA PREVENIR O REDUCIR LA SEQUEDAD, IRRITACION, PRURITO EN LA PIEL
PE2001000150A 2000-02-14 2001-02-12 Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel PE20011092A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50356800A 2000-02-14 2000-02-14
US50316800A 2000-02-14 2000-02-14

Publications (1)

Publication Number Publication Date
PE20011092A1 true PE20011092A1 (es) 2001-11-12

Family

ID=27054407

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000150A PE20011092A1 (es) 2000-02-14 2001-02-12 Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel

Country Status (4)

Country Link
AU (1) AU2001236996A1 (es)
CO (1) CO5261579A1 (es)
PE (1) PE20011092A1 (es)
WO (1) WO2001060336A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119173A1 (en) * 2000-12-22 2002-08-29 Lin Samuel Qcheng Cosmetic compositions for preventing skin irritation
GB0704846D0 (en) * 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
PL214538B1 (pl) * 2009-05-28 2013-08-30 P P F Hasco Lek Spolka Akcyjna Kompozycja liposomowa zawierajaca naproksen i sposób wytwarzania kompozycji liposomowej zawierajacej naproksen
CN113648278A (zh) * 2013-05-03 2021-11-16 立普妥公司 用于给药的运载体和局部组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
DE4021084C1 (en) * 1990-07-03 1991-11-21 Hans Dr. 5024 Pulheim De Lautenschlaeger Fumarate topical compsn. contg. liposome(s) improving bio-availability - esp. for treating psoriasis, contain liposomal structure, alcohol, stabiliser and fumaric acid (deriv.) and are stable and non irritant
US5766628A (en) * 1992-02-24 1998-06-16 Merz + Co. Gmbh & Co. Bath and shower composition having vesicle-forming properties and method for the production and use thereof
DK0582239T3 (da) * 1992-08-04 1999-12-06 Rhone Poulenc Rorer Gmbh Farmaceutisk og/eller kosmetisk formulering
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method

Also Published As

Publication number Publication date
AU2001236996A1 (en) 2001-08-27
CO5261579A1 (es) 2003-03-31
WO2001060336A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ES2103506T3 (es) Utilizacion de acidos hidroxicarboxilicos y sus derivados para la preparacion de composiciones dermatologicas topicas para el tratamiento de arrugas.
ES2058109T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica antimicrobiana topica.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
CO4340618A1 (es) Composicion farmaceutica para liberacion controlada
AR009643A1 (es) Composiciones antimicrobianas para el cuidado personal
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
BRPI0822162B8 (pt) composição farmacêutica para tratamento tópico de doença das unhas ou leito ungueal
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
AR046878A1 (es) Agente endoparasiticida para administracion topica
CR7107A (es) Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion
AR033688A1 (es) Composicion parenteral reconstituible
AR055591A1 (es) Una composicion topica protectora de la piel y su uso
AR023966A1 (es) Una composicion farmaceutica para la prevencion y/o el tratamiento de la enfermedad de parkinson y los sintomas concomitantes de la misma, y el uso de unantagonista dual receptor de adenosina a1 a2a para preparar dicha composicion
CO5160296A1 (es) Nuevas formas de presentacion para agentes activos labiles en medio acido, unidad de agente activo y proceso para la produccion de dicha unidad de agente
AR064263A1 (es) Composiciones farmaceuticas que comprenden un compuesto bisfosfato
ES2175671T3 (es) Agente para el cuidado de la piel.
PE20011092A1 (es) Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel
BR112015027436A8 (pt) composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax
HRP20030907B1 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology
ES2628707T3 (es) Composición tópica potenciada

Legal Events

Date Code Title Description
FD Application declared void or lapsed